Wave Life Sciences

WVE:NAS

Biotechnology

Market Cap

SMALL cap

Share Price ↓

$32.34 (-0.14%)

YTD Return ↓

-0.22%

since start of 2019

P/E Ratio

-6.05

Corporate Values

Carbon Footprint
Pollution Prevention
Water Conservation
Data & Privacy Protection
Consumer Health, Wellness & Safety
Employee Ownership, Satisfaction, Benefits & Pay
Workplace Health and Safety
Integrity of Corporate Governance
Ethical Practices
Usage of Conflict Materials
Forced Labor
Diversity of Corporate Leadership

Legend

About

Biotechnology Founded 2012

Wave Life Sciences Ltd. operates as a preclinical biopharmaceutical company, which engages in the development and provision of nucleic acid therapeutics. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Cambridge, MA.

website

Headquarters

Suite 12-00

7 Straits View

Marina One East Tower

Singapore, Central Singapore 018936

65..6236.3388

Executives

Name	Title	Gender
Gregory L. Verdine, PhD	Chairman	Male
Paul B. Bolno, MD, MBA	President, Chief Executive Officer & Director	Male
Keith Regnante, MBA	Chief Financial Officer	Male
Linda K. Rockett	General Counsel	Female
Takeshi Wada	Founder	Male
Peter Lasky	Chief Human Resources Officer & Senior VP	Male

Mindful Investing Summary

Legend

Carbon Footprint

— N/A
Pollution Prevention

— N/A
Water Conservation

— N/A
Data & Privacy Protection

— N/A
Consumer Health, Wellness & Safety

— N/A
Employee Ownership, Satisfaction, Benefits & Pay

— N/A
Workplace Health and Safety

— N/A
Integrity of Corporate Governance

— N/A
Ethical Practices

— N/A
Usage of Conflict Materials

— N/A
Forced Labor

— N/A
Diversity of Corporate Leadership

1 N/A

Wave Life Sciences - Competitors and Related Companies

How Wave Life Sciences stacks up to its peers in the Biotechnology industry or with competing business segments.